Sign inGet started

Inrig Jula

Insider CIK 1902368 · TVTX EVP, Head of R&D & CMO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TVTX Travere Therapeutics, Inc. M Exercise deriv2026-09-152026-09-1732,395— $043,605SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-1717,284$62.62 $1.08M102,491SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-171,600$63.69 $101.9K100,891SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-17400$65.31 $26.1K100,491SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-1725,390$62.02 $1.57M119,775SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2026-09-152026-09-1732,395$8.93 $289.3K145,165SEC↗
TVTX Travere Therapeutics, Inc. M Exercise deriv2026-09-152026-09-1732,395— $043,605SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-17400$65.31 $26.1K100,491SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-171,600$63.69 $101.9K100,891SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-1717,284$62.62 $1.08M102,491SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-09-152026-09-1725,390$62.02 $1.57M119,775SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2026-09-152026-09-1732,395$8.93 $289.3K145,165SEC↗
TVTX Travere Therapeutics, Inc. G Gift2026-06-222026-06-22468— $0112,770SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-05-062026-05-06311$43.95 $13.7K113,238SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-05-052026-05-062,174$46.65 $101.4K113,549SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2026-05-042026-05-068,500— $08,500SEC↗
TVTX Travere Therapeutics, Inc. M Exercise deriv2026-05-042026-05-064,250— $04,250SEC↗
TVTX Travere Therapeutics, Inc. M Exercise deriv2026-05-042026-05-0620,000— $034,500SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-05-042026-05-0620,000$45.00 $900.0K111,473SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2026-05-042026-05-0620,000$22.40 $448.0K131,473SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2026-05-042026-05-064,250— $0115,723SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-04-152026-04-151,018$42.61 $43.4K111,473SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-04-142026-04-157,215$41.93 $302.5K112,491SEC↗
TVTX Travere Therapeutics, Inc. A Award2026-04-132026-04-1514,000— $0119,706SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-02-042026-02-051,547$32.11 $49.7K105,938SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-02-042026-02-05232$32.85 $7.6K105,706SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-02-032026-02-036,956$32.12 $223.4K107,485SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2026-01-312026-02-0375,000— $075,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2026-01-312026-02-0328,130— $0114,441SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-01-062026-01-07445$37.75 $16.8K86,311SEC↗
TVTX Travere Therapeutics, Inc. S Sale2026-01-052026-01-072,031$40.18 $81.6K86,756SEC↗
TVTX Travere Therapeutics, Inc. M Exercise deriv2025-12-242025-12-2915,000— $076,000SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2025-12-242025-12-2915,000$8.93 $133.9K103,787SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-12-242025-12-2915,000$42.00 $630.0K88,787SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-07-012025-07-02815$14.65 $11.9K88,787SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-02-122025-02-122,568$23.53 $60.4K89,602SEC↗
TVTX Travere Therapeutics, Inc. M Exercise deriv2025-02-102025-02-128,000— $00SEC↗
TVTX Travere Therapeutics, Inc. M Exercise2025-02-102025-02-128,000— $092,170SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-02-042025-02-041,066$20.11 $21.4K84,170SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-02-032025-02-044,207$20.12 $84.6K85,236SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2025-01-312025-02-04100,000— $0100,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2025-01-312025-02-0430,000— $089,443SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-01-062025-01-06440$18.76 $8.3K59,443SEC↗
TVTX Travere Therapeutics, Inc. S Sale2025-01-032025-01-062,066$19.10 $39.5K59,883SEC↗
TVTX Travere Therapeutics, Inc. S Sale2024-09-102024-09-10684$12.98 $8.9K61,949SEC↗
TVTX Travere Therapeutics, Inc. S Sale2024-09-092024-09-092,191$11.52 $25.2K62,633SEC↗
TVTX Travere Therapeutics, Inc. A Award2024-09-052024-09-096,750— $064,824SEC↗
TVTX Travere Therapeutics, Inc. S Sale2024-02-012024-02-022,174$8.53 $18.5K58,074SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2024-01-312024-02-0291,000— $091,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2024-01-312024-02-0225,000— $060,248SEC↗
TVTX Travere Therapeutics, Inc. S Sale2024-01-042024-01-05440$9.17 $4.0K35,248SEC↗
TVTX Travere Therapeutics, Inc. S Sale2024-01-032024-01-052,069$9.48 $19.6K35,688SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2023-01-312023-02-026,750— $06,750SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2023-01-312023-02-0254,500— $054,500SEC↗
TVTX Travere Therapeutics, Inc. A Award2023-01-312023-02-0220,250— $037,757SEC↗
TVTX Travere Therapeutics, Inc. S Sale2023-01-052023-01-06442$20.75 $9.2K17,507SEC↗
TVTX Travere Therapeutics, Inc. S Sale2023-01-042023-01-062,051$20.75 $42.6K17,949SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2022-01-312022-02-028,000— $08,000SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2022-01-012022-01-0480,000— $080,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2022-01-012022-01-0420,000— $020,000SEC↗